Duchenne Muscular Dystrophy Drugs Market Size 2034

hat ein neuen Blog hinzugefügt Andere

2025-10-09 09:35:54

Duchenne Muscular Dystrophy (DMD) drugs are specialized therapies aimed at managing and treating DMD, a rare and severe genetic disorder caused by mutations in the dystrophin gene. This condition leads to progressive muscle degeneration and weakness, primarily affecting boys from early childhood. While there is no definitive cure, current drugs focus on slowing disease progression, improving...

0 Kommentare 0 Geteilt 267 Ansichten 0 Bewertungen